Publications 2015

  1. Mastorakos P, Kambhampati SP, Mishra MK, Wu TT, Song E, Hanes JS, Kannan RM. (2015) Hydroxyl PAMAM dendrimer-based gene vectors for transgene delivery to human retinal pigment epithelial cells, Nanoscale, 7:3845.
  2. Maisel K, Ensign LM, Reddy M, Cone R, Hanes J. (2015) Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse, J Control Rel, 197:48-57.
  3. Yu T, Chan KWY, Anonuevo A, Song X, Schuster BS, Chattopadhyay S, Xu Q, Oskolkov N, Patel H, Ensign LM, van Zjil PCM, McMahon MT, Hanes J. (2015) Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: Demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI), Nanomedicine, 11(2):401-5.
  4. Li Y, San BH, Kessler JL, Kim JH, Xu Q, Hanes J, Yu SM.(2015) Non-covalent photo-patterning of gelatin matrices using caged collagen mimetic peptides, Macromol Biosci, 15(1):52-62.
  5. Schneider CS, Perez JG, Cheng E, Zhang C, Mastorakos P, Hanes J, Winkles JA, Woodworth GF, Kim AJ. (2015) Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells, Biomaterials, 42:45-51.
  6. Pan Q, Xu Q, Boylan NJ, Lamb NW, Emmert G, Yang JC, Tang L, Heflin T, Alwadani S, Eberhardt CG, Stark WJ, Hanes J. (2015) Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats, J Control Release, 201:32-40.
  7. Lu HD, Spiegel A, Hurley A, Perez LJ, Maisel K, Ensign LM, Hanes J, Bassler BL, Semmelhack MF, Prud’homme RK, Modulating Vibrio cholerae Quorum-Sensing-Controlled Communication Using Autoinducer-Loaded Nanoparticles, Nanolett, 15(4):2235-41.
  8. Kambhampati SP, Mishra MK, Mastorakos P, Oh Y, Lutty GA, Kannan RM. (2015) Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells, Eur J Pharm Biopharm, 95(Pt B):239-49.
  9. Mastorakos P, Zhang C, Berry S, Oh Y, Lee S, Eberhart CG, Woodworth GF, Suk JS, Hanes J. (2015) Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain, Adv Healthc Mater, 4(7):1023-33.
  10. Zhang F, Mastorakos P, Mishra MK, Mangraviti A, Hwang L, Zhou J, Hanes J, Brem H, Olivi A, Tyler B, Kannan RM.(2015) Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers, Biomaterials, 52:507-16.
  11. Schuster BS, Ensign LM, Allan DB, Suk JS, Hanes J. (2015) Particle tracking in drug and gene delivery research: State-of-the-art applications and methods, Adv Drug Deliv Rev, 91:70-91.
  12. Maisel K, Chattopadhyay S, Moench T, Hendrix C, Cone R, Ensign LM, Hanes J. (2015) Enema ion compositions for enhancing colorectal drug delivery, J Control Release, 209:280-7.
  13. Mastorakos P, da Silva AL, Chisholm J, Song E, Choi WK, Boyle MP, Morales MM, Hanes J, Suk JS. (2015) Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy, Proc Natl Acad Sci USA, 112(28):8720-5.
  14. Xu Q, Ensign LM, Boylan NJ, Schön A, Gong X, Yang JC, Lamb NW, Cai S, Yu T, Freire E, Hanes J. (2015) Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo, ACS Nano, 9(9):9217-27.
  15. Zhang F, Lin YA, Kannan S, Kannan RM. (2015) Targeting specific cells in the brain with nanomedicines for CNS therapies, J Control Release, in press.
  16. Baker KC, Maerz T, Saad H, Shaheen P, Kannan RM. (2015) In vivo bone formation by and inflammatory response to resorbable polymer-nanoclay constructs, Nanomedicine, 11(8):1871-81.
  17. Kambhampati SP, Clunies-Ross AJ, Bhutto I, Mishra MK, Edwards M, McLeod DS, Kannan RM, Lutty G. (2015) Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina, Invest Ophthalmol Vis Sci, 56(8):4413-24.
  18. Nance E, Porambo M, Zhang F, Mishra MK, Buelow M, Getzenberg R, Johnston M, Kannan RM, Fatemi A, Kannan S. (2015) Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury, J Control Release, 214:112-20.
  19. Hanes J, Ensign L, Kannan R, Soo Suk J. (2015) Editorial, J Control Release, 219:1.
  20. Mitragotri S, Hanes J. (2015) Journal of Drug Targeting Life Time Achievement Award for Prof. Robert Langer, J Drug Target, 23(7-8):579.
  21. Zhang F, Mastorakos P, Mishra MK, Mangraviti A, Hwang L, Zhou J, Hanes J, Brem H, Olivi A, Tyler B, Kannan RM. (2015) Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers, Biomaterials, 52:507-16.
  22. Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. (2015) PEGylation as a strategy for improving nanoparticle-based drug and gene delivery, Adv Drug Deliv Rev, in press.
  23. Mastorakos P, Song E, Zhang C, Berry S, Park HW, Kim YE, Park JS, Lee S, Suk JS, Hanes J. (2015) Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain, Small, in press.
  24. Mead BP, Mastorakos P, Suk JS, Klibanov AL, Hanes J, Price RJ. (2015) Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound, J Control Release, in press.
  25. Oh Y, Park O, Swierczewska M, Park J-S, Kim TH, Lim S-M, Eom H, Jo DG, Lee C-E, Kechrid R, Mastorakos P, Zhang C, Hahn SK, Jeon O-C, Byun Y, Kim K, Hanes J, Lee KC, Pomper MG, Gao B, Lee S. (2015) PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by targeting activated hepatic stellate cells, Hepatology, in press.
  26. Oh Y, Swierczewska M, Kim TH, Lim SM, Eom HN, Park JH, Na DH, Kim K, Lee KC, Pomper MG, Lee S, Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors. Journal of Controlled Release, 2015; 220(Pt B): 671-81. PMID: 26381901